David Scadden

Professor, Harvard University; Physician-Scientist, Massachusetts General Hospital

David Scadden is a prominent physician-scientist and leader in the field of stem cell biology and regenerative medicine who serves as a Director on the Board of Editas Medicine. Here are some key details about Dr. Scadden:

Professional Roles and Affiliations

Gerald and Darlene Jordan Professor of Medicine at Harvard University2 3
Co-Director of the Harvard Stem Cell Institute2 3
Director of the Center for Regenerative Medicine at Massachusetts General Hospital2 3
Professor and Chair emeritus of the Harvard University Department of Stem Cell and Regenerative Biology2 3

Research Focus

Dr. Scadden's research emphasizes:

Using multidisciplinary approaches to develop novel therapies for blood diseases2 3
Studying the bone marrow microenvironment and stem cell niche2 3
Exploring fundamental biology of blood cell production with a focus on therapeutic applications2 3

Industry Involvement

Director at Editas Medicine (since 2019)1 4
Director at Agios Pharmaceuticals2 3
Director at Magenta Therapeutics2 3
Founder of biotechnology companies including Fate Therapeutics and Magenta Therapeutics3

Honors and Memberships

Member of the National Academy of Medicine2 3
Fellow of the American Academy of Arts and Sciences2 3
Fellow of the American Association for the Advancement of Science2 3
Fellow of the American College of Physicians2 3

Education

Undergraduate degree from Bucknell University4
Doctorate degree from Case Western Reserve University4
Doctorate degree from the University of Lund4

Dr. Scadden brings extensive expertise in stem cell biology, hematology, and oncology to his role at Editas Medicine, contributing to the company's efforts in developing genome editing therapies.